Cargando…

Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377627/
https://www.ncbi.nlm.nih.gov/pubmed/37509332
http://dx.doi.org/10.3390/cancers15143668
_version_ 1785079564443058176
collection PubMed
description
format Online
Article
Text
id pubmed-10377627
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103776272023-07-29 Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 Cancers (Basel) Expression of Concern MDPI 2023-07-19 /pmc/articles/PMC10377627/ /pubmed/37509332 http://dx.doi.org/10.3390/cancers15143668 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Expression of Concern
Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title_full Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title_fullStr Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title_full_unstemmed Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title_short Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
title_sort expression of concern: barańska, a.; kanadys, w. oral contraceptive use and breast cancer risk for brca1 and brca2 mutation carriers: systematic review and meta-analysis of case–control studies. cancers 2022, 14, 4774
topic Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377627/
https://www.ncbi.nlm.nih.gov/pubmed/37509332
http://dx.doi.org/10.3390/cancers15143668
work_keys_str_mv AT expressionofconcernbaranskaakanadysworalcontraceptiveuseandbreastcancerriskforbrca1andbrca2mutationcarrierssystematicreviewandmetaanalysisofcasecontrolstudiescancers2022144774